<DOC>
	<DOCNO>NCT00163371</DOCNO>
	<brief_summary>The aim study compare effect ciclesonide inhale one dose level twice daily versus fluticasone propionate inhale one dose level twice daily versus placebo , short-term low leg growth prepubertal child mild persistent asthma . The study duration consist baseline period ( 2 week ) , treatment period ( 2 week treatment ) , wash-out period ( 2 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Effects Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo Lower Leg Growth Prepubertal Children With Mild Persistent Asthma ( 6 12 ) ( BY9010/M1-208 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Main Written inform consent patient 's parent ( ) legal guardian ( ) patient , capable Prepubertal stage Good health exception asthma History asthma least 6 month Currently use rescue medication Main Childbearing potential ( beyond menarche ) Concurrent diseases condition may subsequently affect growth COPD relevant lung diseases cause alternate impairment lung function Concomitant severe disease disease contraindication use inhaled steroid History lifethreatening asthma Current smoking</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Child</keyword>
	<keyword>Fluticasone propionate</keyword>
	<keyword>HPA-axis</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Linear growth rate</keyword>
</DOC>